The complex interplay between calcium and bone metabolism is a critical area of study in the field of endocrinology. Understanding this relationship is essential for healthcare professionals as it has significant implications for the diagnosis and treatment of bone-related disorders.
Calcium plays a central role in bone metabolism, serving as the primary mineral in the bone matrix. It's vital for the structural integrity of the skeleton and is involved in numerous physiological processes, including nerve transmission, muscle contraction, and blood coagulation. Homeostasis of calcium is maintained through a delicate balance of intestinal absorption, renal excretion, and bone resorption and formation.
The regulation of calcium and bone metabolism is mediated by several hormones, including parathyroid hormone (PTH), vitamin D, and calcitonin. PTH and vitamin D increase serum calcium levels by enhancing intestinal absorption, renal reabsorption, and bone resorption. In contrast, calcitonin decreases serum calcium levels by inhibiting osteoclast activity and promoting calcium deposition in bones.
Disruptions in the calcium-bone metabolism axis can lead to various pathological conditions, such as osteoporosis, hypercalcemia, and hypocalcemia. Therefore, understanding this relationship is crucial for the management of these disorders. For instance, in osteoporosis, therapies aim to inhibit bone resorption and promote bone formation, thereby restoring the balance in calcium and bone metabolism.
Understanding the intricate relationship between calcium and bone metabolism is crucial for healthcare professionals. It not only enhances our understanding of bone health but also informs the diagnosis and treatment of a range of bone-related disorders. Continued research in this area will undoubtedly lead to improved strategies for maintaining bone health and managing bone-related diseases.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation